Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Liver Diseases

  Free Subscription


Articles published in Br J Surg

Retrieve available abstracts of 41 articles:
HTML format



Single Articles


    September 2025
  1. REESE T, Bjork D, Longva AMH, Kiim KS, et al
    Oncological safety of portal vein embolization without prior tumour clearance in the future liver remnant followed by one-stage hepatectomy for bilateral colorectal liver metastases.
    Br J Surg. 2025;112:znaf198.
    PubMed     Abstract available


  2. HALLET J, Acher AW, Jivraj N, McIsaac DI, et al
    Association between anaesthetist hepatopancreatobiliary volume and outcomes.
    Br J Surg. 2025;112:znaf192.
    PubMed    


    August 2025
  3. HUIBERS A, Wong A, Burgmans M, Ny L, et al
    Management of liver metastases from uveal melanoma.
    Br J Surg. 2025;112:znaf130.
    PubMed     Abstract available


    May 2025
  4. ACIDI B, Haddad A, Vauthey JN, Tran Cao HS, et al
    Advancing hepatic augmentation for safer hepatic surgery: insights into portal and hepatic vein embolization strategies.
    Br J Surg. 2025;112:znaf115.
    PubMed    


    April 2025
  5. LOPEZ-LOPEZ V, Mohamed AH, Lopez-Conesa A, Fernandez D, et al
    Implementing laparoscopic liver surgery in Sub-Saharan Africa: a capacity-building and hepatopancreatobiliary mentorship model.
    Br J Surg. 2025;112:znaf107.
    PubMed    


  6. BARTHOLOMA WC, Gilg S, Lundberg P, Larsen PN, et al
    Magnetic resonance-derived hepatic uptake index improves the identification of patients at risk of severe post-hepatectomy liver failure.
    Br J Surg. 2025;112:znaf103.
    PubMed     Abstract available


    March 2025
  7. KAWASHIMA J, Akabane M, Khalil M, Woldesenbet S, et al
    Tumour burden predicts outcomes after curative resection of multifocal intrahepatic cholangiocarcinoma.
    Br J Surg. 2025;112:znaf050.
    PubMed     Abstract available


  8. SOREIDE K
    Resection of multifocal intrahepatic cholangiocarcinoma.
    Br J Surg. 2025;112:znaf048.
    PubMed    


  9. NING J, Dai C, Liu Q, Lin H, et al
    Application of the associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) technique in conversion therapy for hepatocellular carcinoma.
    Br J Surg. 2025;112:znaf067.
    PubMed    


  10. WANG X, Liang J, Cao L, Liu Y, et al
    Laparoscopic in situ anatomical resection of posterosuperior liver segments: preservation of segment 6 regardless of the presence of the inferior right hepatic vein.
    Br J Surg. 2025;112:znaf066.
    PubMed    


  11. YAQUB S, Busund S, Smedman TM, Syversveen T, et al
    Liver transplantation for locally advanced non-resectable intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: early results from the TESLA trial.
    Br J Surg. 2025;112:znaf054.
    PubMed    


    February 2025
  12. KAWAHARA W, Rivera B, Roberts J, Huang C, et al
    Laparoscopic left hemihepatectomy using the Arantius-first approach after 90Y transarterial radioembolization and immunotherapy in a cirrhotic patient.
    Br J Surg. 2025;112:znae305.
    PubMed    


    October 2024
  13. GIANNONE F, Del Zompo F, Saviano A, Pencreach E, et al
    Impact of genetic alterations on long-term outcomes in resectable intrahepatic cholangiocarcinoma: meta-analysis.
    Br J Surg. 2024;111:znae257.
    PubMed     Abstract available


  14. PERRI G, Sparrelid E, Siriwardena AK, Marchegiani G, et al
    Estimation of intraoperative blood loss in hepatopancreatobiliary surgery: a Delphi consensus process of the European-African Hepato-Pancreato-Biliary Association (E-AHPBA).
    Br J Surg. 2024;111:znae256.
    PubMed    


    August 2024
  15. PAOLUCCI I, Albuquerque Marques Silva J, Lin YM, Laimer G, et al
    Identification of A0 minimum ablative margins for colorectal liver metastases: multicentre, retrospective study using deformable CT registration and artificial intelligence-based autosegmentation.
    Br J Surg. 2024;111:znae165.
    PubMed     Abstract available


  16. SOREIDE K, Kok NFM
    Curative-intent ablation margins (A0) for colorectal liver metastasis: more burning questions.
    Br J Surg. 2024;111:znae184.
    PubMed    


  17. KITAHAMA T, Ashida R, Ohgi K, Yamada M, et al
    Laparoscopic right anterior inferior segmentectomy for hepatocellular carcinoma in a patient with congenital absence of the portal vein: intrahepatic artery-guided simulation.
    Br J Surg. 2024;111:znae210.
    PubMed    


  18. BOZKURT E, Sijberden JP, Langella S, Cipriani F, et al
    Laparoscopic versus open right hepatectomy for colorectal liver metastases after portal vein embolization: international multicentre study.
    Br J Surg. 2024;111:znae181.
    PubMed     Abstract available


    July 2024
  19. BAHRI S, Brown L, Perin G, Balasubramanian SP, et al
    Comment on: Laparoscopic liver resection versus radiofrequency ablation for small hepatocellular carcinoma: randomized clinical trial.
    Br J Surg. 2024;111:znae171.
    PubMed    


  20. MARGONIS GA, Wang JJ, Boerner T, Moretto R, et al
    Hepatectomy versus systemic therapy for liver-limited BRAF V600E-mutated colorectal liver metastases: multicentre retrospective study.
    Br J Surg. 2024;111:znae176.
    PubMed     Abstract available


    May 2024
  21. OLTHOF K, Smit J, Fusaglia M, Kok N, et al
    A surgical navigation system to aid the ablation of vanished colorectal liver metastases.
    Br J Surg. 2024;111:znae110.
    PubMed    


  22. JONES RP
    Lesional liver biopsies: better treatments, better studies, better science.
    Br J Surg. 2024;111:znae063.
    PubMed    


  23. DE GRAAFF MR, Hendriks TE, Wouters M, Nielen M, et al
    Assessing quality of hepato-pancreato-biliary surgery: nationwide benchmarking.
    Br J Surg. 2024;111:znae119.
    PubMed     Abstract available


    April 2024
  24. KRUL MF, Kok NFM, Osmani H, Buisman FE, et al
    Hepatic arterial infusion pump chemotherapy combined with systemic chemotherapy for borderline resectable and unresectable colorectal liver metastases: phase II feasibility study.
    Br J Surg. 2024;111:znae089.
    PubMed     Abstract available


  25. AKABANE M, Bekki Y, Imaoka Y, Inaba Y, et al
    Impact of donor characteristics on hepatocellular carcinoma recurrence after liver transplantation.
    Br J Surg. 2024;111:znae080.
    PubMed    


  26. JOLIAT GR, de Man R, Rijckborst V, Cimino M, et al
    Long-term outcomes of ruptured hepatocellular carcinoma: international multicentre study.
    Br J Surg. 2024;111:znae093.
    PubMed    


  27. KORENBLIK R, Heil J, Smits J, James S, et al
    Liver regeneration after portal and hepatic vein embolization improves overall survival compared with portal vein embolization alone: mid-term survival analysis of the multicentre DRAGON 0 cohort.
    Br J Surg. 2024;111:znae087.
    PubMed     Abstract available


  28. SONG J, Cao L, Ma K, Li J, et al
    Laparoscopic liver resection versus radiofrequency ablation for small hepatocellular carcinoma: randomized clinical trial.
    Br J Surg. 2024;111:znae099.
    PubMed     Abstract available


    March 2024
  29. PENG W, Wu Y, Zhang X, Li C, et al
    Liver transplantation for advanced hepatocellular carcinoma after downstaging with consequential lenvatinib, transcatheter arterial chemoembolization and camrelizumab.
    Br J Surg. 2024;111:znae048.
    PubMed    


  30. FAN ZQ, Serenari M, Lv X, Schwartz M, et al
    Prognostic significance of nodular number in patients undergoing hepatectomy of intermediate-stage hepatocellular carcinoma.
    Br J Surg. 2024;111:znae047.
    PubMed    


  31. MAJLESARA A, Golriz M, Ramouz A, Khajeh E, et al
    Portal vein arterialization as a salvage method in advanced hepatopancreatobiliary surgery.
    Br J Surg. 2024;111:znae053.
    PubMed    


  32. MARTIN-CULLELL B, Virgili AC, Riera P, Fumagalli C, et al
    Histopathological, Clinical, And Molecular (HICAM) score for patients with colorectal liver metastases.
    Br J Surg. 2024;111:znae016.
    PubMed     Abstract available


    January 2024
  33. BAUMGARTNER R, Engstrand J, Rajala P, Grip J, et al
    Comparing the accuracy of prediction models to detect clinically relevant post-hepatectomy liver failure early after major hepatectomy.
    Br J Surg. 2024;111:znad433.
    PubMed     Abstract available


  34. TZEDAKIS S, Yzhaky Shapira O, Schwarzinger M, Katsahian S, et al
    COVID-19 and excess mortality of patients with liver cancer in France, January 2020-September 2022.
    Br J Surg. 2024;111:znad359.
    PubMed    


  35. ENDO Y, Pawlik TM
    Author response to: Comment on: Liver transplantation for elderly patients with early-stage hepatocellular carcinoma.
    Br J Surg. 2024;111:znad423.
    PubMed    


  36. MALIK AK, Figueiredo R, White SA
    Comment on: Liver transplantation for elderly patients with early-stage hepatocellular carcinoma.
    Br J Surg. 2024;111:znad426.
    PubMed    


    November 2023
  37. ARNTZ P, Olthof PB
    Assessment of liver function before major hepatectomy.
    Br J Surg. 2023;110:1588-1589.
    PubMed    


    October 2023

  38. Corrigendum to: Variation in treatment of intrahepatic cholangiocarcinoma: a nationwide multicentre study.
    Br J Surg. 2023 Oct 31:znad365. doi: 10.1093.
    PubMed    


    September 2023
  39. PRIMAVESI F, Maglione M, Cipriani F, Denecke T, et al
    E-AHPBA-ESSO-ESSR Innsbruck consensus guidelines for preoperative liver function assessment before hepatectomy.
    Br J Surg. 2023;110:1331-1347.
    PubMed     Abstract available


  40. KATAOKA K, Takahashi K, Takeuchi J, Ito K, et al
    Author response to: Comment on: Correlation between recurrence-free survival and overall survival after upfront surgery for resected colorectal liver metastases.
    Br J Surg. 2023;110:1407.
    PubMed    


  41. VOIGT KR, Wullaert L, de Graaff MR, Verhoef C, et al
    Association between textbook outcome and long-term survival after surgery for colorectal liver metastases.
    Br J Surg. 2023;110:1284-1287.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.